NextGen is leveraging cutting edge research collaborations to achieve breakthroughs in anti-cancer treatment in order to license its valuable patented drug product candidates to Big Pharma companies. NextGen is currently seeking partners for its pipeline programmes, on either a collaborative or licensing basis. For further details and to discuss partnering opportunities, please contact:

NextGen Bioscience, Inc
29 Harley Street
London W1G 9QR
United Kingdom

Phone: +44 207 247 8186 

Email: info@nextgenbioscience.com